Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 39,627 |
|
|||||
| News | - | ||||||
| Day High | 1.44 | Low High |
|||||
| Day Low | 1.27 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 6.20% | 1.37 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.29 | 1.27 | 1.44 | 1.37 | 1.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 352 | 39,627 | $ 1.39 | $ 55,045 | - | 1.22 - 20.66 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 202 | $ 1.37 | USD |
Hepion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.07M | 4.34M | - | 0 | -45.34M | -10.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.09 | 2.20 | 1.22 | 1.54 | 117,250 | -0.72 | -34.45% |
| 1 Month | 2.44 | 2.8999 | 1.22 | 1.93 | 55,576 | -1.07 | -43.85% |
| 3 Months | 1.73 | 3.4899 | 1.22 | 2.21 | 79,513 | -0.36 | -20.81% |
| 6 Months | 4.52 | 4.8398 | 1.22 | 2.63 | 73,532 | -3.15 | -69.69% |
| 1 Year | 13.60 | 20.66 | 1.22 | 12.67 | 148,467 | -12.23 | -89.93% |
| 3 Years | 34.60 | 46.368 | 1.22 | 26.85 | 529,482 | -33.23 | -96.04% |
| 5 Years | 62.20 | 167.00 | 1.22 | 45.91 | 1,042,073 | -60.83 | -97.80% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |
